Alprostadil and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is reported as a side effect among people who take Alprostadil (alprostadil), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Neurontin, and have Atherosclerosis obliterans.

The phase IV clinical study analyzes which people have Drowsiness when taking Alprostadil. It is created by eHealthMe based on reports of 2,637 people who have side effects when taking Alprostadil from the FDA, and is updated regularly.

What is Alprostadil?

Alprostadil has active ingredients of alprostadil. It is often used in erection problems. eHealthMe is studying from 2,653 Alprostadil users. Check the latest studies of Alprostadil.

What is Drowsiness?

Drowsiness is found to be associated with 2,865 drugs and 4,797 conditions by eHealthMe. Check the latest studies of Drowsiness.

On Jul, 22, 2026

2,637 people reported to have side effects when taking Alprostadil.
Among them, 14 people (0.53%) have Drowsiness.

Among these 14 people:

How long have people been on Alprostadil when they have Drowsiness? *

What is the gender of people who have Drowsiness when taking Alprostadil? *

female: 21.43 %
male: 78.57 %

What is the age of people who have Drowsiness when taking Alprostadil? *

What are other drugs people take besides Alprostadil? *

What are other side effects people have besides Drowsiness? *

Fever: 5 people, 35.71%
Snoring: 2 people, 14.29%
Feeling Abnormal: 2 people, 14.29%
Encephalopathy (functioning of the brain is affected by some agent or condition): 2 people, 14.29%
Hypervigilance: 2 people, 14.29%
Miosis (constriction of the pupil of the eye, resulting from a normal response to an increase in light): 2 people, 14.29%
Physical Assault: 2 people, 14.29%
Pneumonia: 2 people, 14.29%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 2 people, 14.29%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 2 people, 14.29%

What are the existing conditions these people have? *

Atherosclerosis Obliterans (disorder of medium and large arteries of the lower extremity): 3 people, 21.43%
Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 2 people, 14.29%
Neuralgia (pain in one or more nerves): 2 people, 14.29%
Herpes Zoster: 2 people, 14.29%
Pain: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Alprostadil and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alprostadil:

Alprostadil (2,653 reports)

Drowsiness treatments and more:

Drowsiness (269,040 reports)

Browse all side effects of Alprostadil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drowsiness:

Drowsiness (2,865 drugs)

Browse all the conditions that are associated with Drowsiness:

Drowsiness (4,797 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alprostadil (the active ingredients of Alprostadil) and Alprostadil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.